/C O R R E C T I O N -- Genzyme Corporation/
10 Juli 2007 - 8:44PM
PR Newswire (US)
In the news release, Genzyme Completes Tender Offer to Acquire
Bioenvision, Inc., issued earlier today by Genzyme Corporation over
PR Newswire, we are advised by Genzyme that the company will
purchase approximately 22 percent of outstanding shares of
Bioenvision common stock on an as-converted basis, including the
100 percent of outstanding shares of preferred stock that have
already been tendered. Further, as of today at 12:01 a.m., a total
of approximately 8,706,644 shares of Bioenvision common stock and
2,250,000 shares of Bioenvision preferred stock had been tendered
and not withdrawn. DATASOURCE: Genzyme Corporation Web site:
http://www.genzyme.com/ Company News On-Call:
http://www.prnewswire.com/comp/113803.html
Copyright